However, regarding our treatment failure in this case, we consider that undetermined genetic mutations beyond BRAF V600E might be involved, such as the PI3K/AKT/mTOR pathway or CSF1R genes reported in LCH and ECD [27]. This evidence concerns the gene BRAF and Langerhans cell histiocytosis.